ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
ResoTher Pharma A/S: operating_income
One fact, its scope and the complete path back to the official record.
Reported value
-7.084M{"amount": -7084000.0, "concept": "ifrs-full:ProfitLossFromOperatingActivities"}- Entity
- ResoTher Pharma A/S
- Metric
- operating_income
- Period
- 2020-01-01 – 2020-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:5493004IM45YLQPU2R19:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:18:56.525325+02:00
Raw response SHA-256
e4adb54f5c3a5d10fb92c778497f2c05…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.